Sauget Facility Hours
|
Friday 12/6 |
Closed |
|
|
Saturday & Sunday |
Closed |
|
|
w/o 12/9 |
TBD |
|
Crysalis: Bioprocess Transformation
Turnkey Bio-Manufacturing
Crysalis is a bioprocess technology demonstration, manufacturing, and licensing company. We implement our proprietary portfolio of Intellectual Property and proven capabilities to design, build, and operate turnkey biochemical plants. Crysalis is a leader in manufacturing the next generation of low Carbon Intensity (CI) biofuels and biochemicals.
Turnkey Bio-Manufacturing
Crysalis is a bioprocess technology demonstration, manufacturing, and licensing company. We implement our proprietary portfolio of Intellectual Property and proven capabilities to design, build, and operate turnkey biochemical plants. Crysalis is a leader in manufacturing the next generation of low Carbon Intensity (CI) biofuels and biochemicals.
Press Releases
September 30 2024
Crysalis Biosciences Inc. Invests $239.5 Million for Sustainable Aviation Fuel Facility in Sauget
Sauget, IL, United States, September 5, 2024 — Governor JB Pritzker, Crysalis Biosciences Inc. and the Illinois Department of Commerce and Economic Opportunity (DCEO) today announced a Reimagining Energy and Vehicles in Illinois (REV Illinois) agreement for Crysalis’ $239.5 million investment to develop a first-of-its-kind sustainable aviation fuel (SAF) plant. The investment, which creates at least 35 new jobs in Sauget, will transform the fuel and chemical industry while reducing the carbon footprint in Illinois by manufacturing SAF, an alternative jet fuel made with a smaller carbon footprint.
August 5 2024
Crysalis Biosciences Announces Significant Milestones and Closure of Investment from SAFFA Fund I, LP, anchored by Airbus
Sauget, IL, United States, August 5, 2024 — Crysalis Biosciences Inc., a pioneering biochemicals manufacturing company, announced the achievement of several key milestones and the successful closure of an investment by Airbus, marking a significant step forward in the company’s mission to manufacture zero carbon biochemicals creating green chemical manufacturing infrastructure in the United States.
July 23 2024
Airbus and partners invest in Sustainable Aviation Fuel financing fund
Farnborough, United Kingdom, 23 July 2024 — Airbus, the Air France-KLM Group, Associated Energy Group, LLC, BNP Paribas, Burnham Sterling, Mitsubishi HC Capital Inc. and Qantas Airways Limited co-invested in a Sustainable Aviation Fuel (SAF) financing fund to accelerate the production of SAF.
May 15 2023
Bio-based Transformation of Organic Solvents for Achieving Carbon Neutrality
Nitto Denko Corporation (hereinafter referred to as “Nitto”) is pleased to announce that it has signed a contract with Crysalis Biosciences Inc., (hereinafter referred to as “Crysalis”) to jointly develop plant-derived acetonitrile as a bio-based solvent, as well as to invest in Crysalis, as part of its efforts to achieve carbon neutrality.
Sign Up For Our News
Enter your email to receive the latest Crysalis news.
Sign Up For Our News
Enter your email to receive the latest Crysalis news.
Current Flagship Projects
Sustainable Aviation Fuel
Crysalis recently purchased a 55 Mgal/yr ethanol facility in Sauget, Illinois. We are transforming this 57-acre asset from conventional fuel ethanol production to a 30 Mgal/yr Sustainable Aviation Fuel (SAF) production facility. This $200 MM project applies our intellectual property portfolio with plant design and construction capabilities to retrofit this plant to produce low carbon intensity SAF.
Sustainable
Aviation Fuel
Crysalis recently purchased a 55 Mgal/yr ethanol facility in Sauget, Illinois. We are transforming this 57-acre asset from conventional fuel ethanol production to a 30 Mgal/yr Sustainable Aviation Fuel (SAF) production facility. This $200 MM project applies our intellectual property portfolio with plant design and construction capabilities to retrofit this plant to produce low carbon intensity SAF.
Low-Carbon Acetonitrile:
Crysalis and Nitto Denko Innovation
An increase in the global demand for acetonitrile is emerging, driven by its applications within the pharmaceutical industry and as a solvent for next-generation batteries. Crysalis and Nitto Denko Corporation are partnering to design and build the world’s first bio-based low carbon intensity acetonitrile plant. This 5 kTa/yr bio-acetonitrile plant will help support the world-wide demand for acetonitrile.
©2024 Crysalis Biosciences, Inc.